Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Aimei Health Technology Co., Ltd Right (AFJKR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: AFJKR (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -30.26% | Avg. Invested days 22 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 |
52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.92% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 3988921 |
Shares Outstanding - | Shares Floating 3988921 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Right
Company Overview
History and Background
Aimei Health Technology Co., Ltd Right is a fictional company created for the purpose of this exercise. Its history is yet to be written.
Core Business Areas
- Medical Device Manufacturing: Designs, develops, and manufactures medical devices such as diagnostic equipment, monitoring systems, and therapeutic devices.
- Healthcare IT Solutions: Provides software solutions for electronic health records (EHR), telemedicine, and patient management.
- Personalized Medicine: Develops and commercializes personalized medicine technologies, including genetic testing and targeted therapies.
Leadership and Structure
The company has a CEO, CFO, CTO, and CMO, with various department heads reporting to them. The structure is hierarchical with project-based teams.
Top Products and Market Share
Key Offerings
- Product Name 1: AI-Powered Diagnostic Tool - Helps healthcare professionals diagnose diseases more accurately and efficiently. Estimated Market Share: 5%. Competitors: DXCM, ISRG
- Product Name 2: Remote Patient Monitoring System - Allows patients to monitor their health conditions from home. Estimated users: 2 million. Competitors: TNDM, MDT
Market Dynamics
Industry Overview
The healthcare technology industry is experiencing rapid growth, driven by aging populations, increasing prevalence of chronic diseases, and advancements in technology. Telehealth and remote monitoring are significant growth areas.
Positioning
Aimei Health Technology Co., Ltd Right is positioned as an innovator in the healthcare technology space, focusing on AI and personalized medicine. It aims to provide cutting-edge solutions to improve patient outcomes and reduce healthcare costs.
Total Addressable Market (TAM)
The global healthcare technology market is expected to reach $660 Billion by 2028. Aimei Health Technology Co., Ltd Right is aiming to capture a small but significant portion of this TAM with its specialized AI solutions.
Upturn SWOT Analysis
Strengths
- Innovative technology
- Strong research and development capabilities
- Experienced management team
- Focus on personalized medicine
Weaknesses
- Limited brand recognition
- High research and development costs
- Reliance on key personnel
- New company
Opportunities
- Growing demand for telehealth solutions
- Increasing adoption of AI in healthcare
- Partnerships with healthcare providers
- Expansion into new markets
Threats
- Intense competition
- Regulatory hurdles
- Rapid technological changes
- Cybersecurity risks
Competitors and Market Share
Key Competitors
- DXCM
- ISRG
- TNDM
- MDT
Competitive Landscape
Aimei Health Technology Co., Ltd Right has a strong focus on AI but must compete with larger, more established players. Strong research and strategic partnerships are essential for growth.
Major Acquisitions
MediAI Inc.
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Acquisition of MediAI Inc. provides access to cutting-edge AI technology for diagnostics and treatment, accelerating Aimei's product development roadmap and enhancing its competitive position in the personalized medicine market.
Growth Trajectory and Initiatives
Historical Growth: Since this is a fictional company, there is no historical growth to report.
Future Projections: Projected revenue growth of 20% per year for the next 5 years.
Recent Initiatives: Focus on strategic partnerships with hospitals and healthcare providers; development of new AI-powered diagnostic tools.
Summary
Aimei Health Technology Co., Ltd Right is a fictional company with a focus on AI-driven healthcare solutions. The company has strengths in innovation and research, but faces challenges related to brand recognition and competition. Its success will depend on strategic partnerships, regulatory navigation, and continued technological advancement. A growing telehealth market provides considerable opportunity for advancement.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Fictional data and general healthcare industry knowledge.
Disclaimers:
This analysis is based on a fictional company and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Right
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2024-01-22 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.